Camarillo startup ImmPACT Bio is joining the pursuit for T-cell immunotherapies with $18 million in its pocket. The company is setting up shop in a Southern California hotbed for the avenue of research, which seeks to treat solid tumors using patients’ own immune cells. That includes efforts from regional heavyweight Amgen and Thousand Oaks-based Atara…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
